Drug Product Development

Product Description

We support our clients from early-stage research and preclinical phase to and beyond market approval by providing comprehensive development services, including 

  • Developability assessment
  • Pre-formulation screening
  • Formulation development
  • Lyophilization process development
  • Forced degradation
  • Stability studies
  • Product characterization 

Coriolis

  • DE
  • 2022
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Specifications
  • Model
    https://www.coriolis-pharma.com/development-services
  • Supplied from
    Germany

Coriolis

  • DE
  • 2022
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Laboratory Services

More Products from Coriolis (2)

  • Analytical Services (GMP and R&D)

    Product Analytical Services (GMP and R&D)

    Our analytical portfolio comprises 200+ different techniques – all performed by Coriolis’ experts in-house. Our offering includes:
    • Aggregate analytics • Particle characterization • Particle identification • Surfactant characterization • Higher order structure analysis • Funcional assays • Chemi...
  • Manufacturing Services

    Product Manufacturing Services

    We support our clients with the production of non-GMP drug product batches for preclinical and indicative stability studies, including
    • Liquid drug product manufacturing • Lyophilized drug product manufacturing • Analytics and stability testing

Coriolis resources (2)